ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

Review Of NTP Could Lead To Administrative Changes

April 18, 1980

FDA Orders More Changes In ESA Label,

August 8, 2008

Collins, Lander, Botstein Win Albany Prize.

March 12, 2010

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Roswell Park Wins High Priority Score, Full Budget Recommendation For Core Grant.

January 11, 2008

Young Elected ACS President, Von eschenback Pres.-Elect.

November 9, 2001